Download - Morbidity and Mortality #19
06 July 2020
Morbidity and Mortality
Weekly Update (MMWU) #19
https://www.who.int/bangladesh/emergencies/coronavirus-disease-(covid-19)-update/
Dead Recovered Confirmed Tested In this issue of COVID-19
Morbidity and Mortality Weekly
Update (MMWU) # 19 (30 June –
06 July 2020):
dashboard with key figures;
detailed epidemiological
update on COVID-19 pandemic
in Bangladesh, week 30 June –
06 July 2020;
daily and weekly distribution of
COVID-19 cases and related
deaths;
growth factor of daily COVID-
19 cases
daily distribution of COVID-19
cases and rolling three-days
average per division;
gender and age distribution of
COVID-19 cases and deaths
overall attack rate and per
division;
death and recovery rates of
closed cases;
comparison data with selected
countries in South East Asia;
and
geographical distribution of
COVID-19 laboratories, number
of COVID-19 tests and Attack
Rate per division.
Tested Confirmed Recovered Dead Hotline
863,307 165,618 76,149 2,096 14.9 million
Test/1 million New Cases Recovery Rate CFR% AR/1 million
5,069 3,201 45.9% 1.27% 972.4
Laboratories PPE Stock PoE Screening
73 COVID-19 Labs
Last days
115,865 Samples
1,171,950
359,588
3,162,783
25,771
62.5%
Inside Dhaka
Tests
193,659
7,029
22.4%
Positive Tests
470,227
351,651
Photo Credit: Social Media, Bangladesh
2 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
1. Highlights
As of 06 July 2020, according to the Institute of Epidemiology, Disease Control and Research (IEDCR), there are
165,618 confirmed COVID-19 cases1 in Bangladesh, including 2,096 related deaths; Case Fatality Rate (CFR) is
1.27%.
On 30 June 2020, the Ministry of Public Administration issued a notification declaring Red Zones in Dhaka South
Corporation, which include Tipu Sultan Road; Tipu Sultan Road; Jahangir Road and Dhaka-Sylhet Highway (from Joykali
Mandir to Baldha Garden) – Outer Road and -Larmini Road; Hore Road; War Road; Rankin Road and Nawab Road -Inner
road. Conditional general holidays in these areas are announced from 4 to 25 July 2020. Full text of the notification:
www.mopa.gov.bd
2. Coordination
On 29 June 2020, WHO published a new interim guidance on Infection prevention and control during health care
when coronavirus disease (COVID-19) is suspected or confirmed. WHO recommendations for outpatient care
include: consideration of alternatives to face-to-face outpatient visits using telemedicine (e.g. telephone consultations
or cell phone videoconference) to provide clinical support without direct contact with the patient; screening, early
recognition and isolation of patients with suspected COVID-19; emphasis on hand hygiene, respiratory hygiene and
medical masks to be used by patients with respiratory symptoms; appropriate use of contact and droplet precautions
when performing clinical exam on patients with suspected COVID-19; prioritization of care of symptomatic patients;
when symptomatic patients are required to wait, ensuring they have a separate waiting area where pa tients can sit at
least one meter apart and provide them with masks; and education of patients and families about the early recognition
of symptoms, basic precautions to be used and which health-care facility they should refer to if any family member
shows signs of COVID-19. Full document: https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2020.4
On 30 June 2020, WHO published a scientific brief on Smoking and COVID-19. The brief concluded that all available
evidence suggests that smoking is associated with increased severity of disease and death in hospitalized COVID-19
patients. Although smoking is likely related to severity, there is no evidence to quantify the risk to smokers of
hospitalization with COVID-19 or of infection by SARS-CoV-2 was found in the peer-reviewed literature. Population-
based studies are needed to address these questions. WHO recommended that tobacco users stop using tobacco.
Proven interventions to help users quit include toll-free quit lines, mobile text-messaging cessation programmes,
nicotine replacement therapies and other approved medications. Full document:
https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Smoking-2020.2
On 30 June 2020, WHO held the 1st Infodemiology2 Conference. The overall aim of this consultation is to take stock
of relevant research and effective practices and define public health research needs in order to advance this field with
the objectives of understand the multidisciplinary nature of infodemic management; identify current examples and tools
to understand, measure and control infodemics; build a public health research agenda to direct focus and investment in
this emerging scientific field; and establish a community of practice and research. Experts from the fields of Epidemiology
& Public Health; Applied Mathematics & Data Science; Digital Health and Technology Applications; Social & Behavioral
Science; Media Studies & Journalism; Marketing, UX & Design; Risk Communication and Community Engagement; Ethics
& Governance and UN agencies and Public health authorities participated in the conference. Full document:
https://www.who.int/news-room/events/detail/2020/06/30/default-calendar/1st-who-infodemiology-conference
1 WHO Bangladesh COVID-19 Situation Reports present official counts of confirmed COVID-19 as announced by the IEDCR and DGHS
on the indicated date. Difference in data between the WHO reports and other sources can result from using different cutoff ti mes for
the aggregation and reporting of the total number of new cases in the country .
2 “infodemiology” is defined as the science of managing infodemics.
3 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
3. Surveillance and Laboratory
Between 9 March and 06 July 2020, according to the Institute of Epidemiology, Disease Control and Research (IEDCR)
there were one-hundred-sixty-five thousand-six-hundred-eighteen (165,618) COVID-19 confirmed by rt-PCR, including
two-thousand nighty-six (2,096) related deaths (CFR 1.27%).
In the current week (epidemiological week 27), in comparison to the previous epidemiological week, the number of
COVID-19 confirmed cases decreased by 3.3% (24,630 and 25,481) but the number of COVID-19 related deaths
increased by 14.9% (315 and 274 respectively), leading the CFR to go up from 1.08% in epidemiological week 26 to
1.28% in the current week.
The figures below are showing the daily and weekly distribution of reported confirmed COVID-19 cases and
deaths, 08 March – 06 July 2020, Bangladesh.
60
45
30
15
0
15
30
45
60
75
90
-4,000
-3,000
-2,000
-1,000
0
1,000
2,000
3,000
4,000
08/03 16/03 24/03 01/04 09/04 17/04 25/04 03/05 11/05 19/05 27/05 04/06 12/06 20/06 28/06 06/07
Num
ber
of D
eath
s (n
=2,0
96)
Num
ber
of C
ase
s (N
=165,6
18)
# Cases # Deaths
Poly. ( # Cases ) Poly. (# Deaths)
0
50
100
150
200
250
300
350
-
5,000
10,000
15,000
20,000
25,000
30,000
w10 w11 w12 w13 w14 w15 w16 w17 w18 w19 w20 w21 w22 w23 w24 w25 w26 w27
Weekl
y D
eath
s
Weekl
y C
ase
s
# Cases # Deaths
4 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
Out of the total 165,618 COVID-19 cases registered as of 06 July 2020, 45.98% (76,149/165.618) - recovered, 1.27%
(2,096) - died and 52.76% (87,373) are active cases.
The figure below is showing active vs recovered confirmed COVID-19 cases outcome per epidemiological week,
08 March – 06 July 2020, Bangladesh.
In the current week (epidemiological week 27), the number of COVID-19 active cases decreased by 96.3%, in comparison
to the previous week (7,417 and 14,557), the number of recovered COVID-19 cases increased by 58.7% (16,898 and
10,650) and the number of COVID-19 related deaths increased by 14.9% (315 and 274 respectively).
The figure below is showing the weekly outcome of reported confirmed COVID-19 cases, 08 March – 06 July 2020,
Bangladesh.
0 T
20 T
40 T
60 T
80 T
100 T
120 T
140 T0 T
10 T
20 T
30 T
40 T
50 T
60 T
70 T
80 T
90 T
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Tho
usa
nd
s
Epi Week
Active cases =
76,149
87,373
Recovered =
8,6
62
10,4
93
14,2
56
16,6
41
12,1
47
14,5
57
7,4
17
4,8
23
26,3
47
10,6
50
16,8
98
51
100
152
170
238
283
292
274 315
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
w10 w11 w12 w13 w14 w15 w16 w17 w18 w19 w20 w21 w22 w23 w24 w25 w26 w27
Weekly Active Weekly Recovery Weekly Deaths
5 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
As of 06 July 2020, there were 78,245 (47.2%) COVID-19 cases with known outcome (closed cases). Out of all closed
cases, 97.3% (76,149/78,245) were cured and 2.7% (2,096) died. The recovery rate of 97% in the closed cases didn’t
show any change since 16 June 2020. The death rate on closed cases in Bangladesh is lower than the 8.0%
(533,621/6,978,964) global average as of 06 July 2020.
The figure below is showing the death and recovery rates over cumulative closed confirmed COVID-19 cases, 08
March – 06 July 2020, Bangladesh.
According to the available data, 26.4% cases were confirmed in people between 31 and 40 years old, 20.5% in the age
group of 21 to 30 years, 19.7% in the age group of 41 to 50 years and 14.7% in the age group between 51 and 60 years
old.
As on 06 July 2020, the highest death rate (30.1%) was reported in the age group of 61 to 70 years old, 24.5% in the
age group between 51 and 60 years and 21.2% in the older age group of 71 and above. Male represented 70% and
80% of the of total reported confirmed COVID-19 cases and deaths respectively.
The table below is showing gender and age distribution the reported confirmed COVID-19 cases and deaths 06
July 2020, Bangladesh.
0%
20%
40%
60%
80%
100%
08/0
3
12/0
3
16/0
3
20/0
3
24/0
3
28/0
3
01/0
4
05/0
4
09/0
4
13/0
4
17/0
4
21/0
4
25/0
4
29/0
4
03/0
5
07/0
5
11/0
5
15/0
5
19/0
5
23/0
5
27/0
5
31/0
5
04/0
6
08/0
6
12/0
6
16/0
6
20/0
6
24/0
6
28/0
6
02/0
7
06/0
7
Num
ber
of C
lose
d C
ase
s (N
=78,2
45)
Death% Recovery%
20,000 15,000 10,000 5,000 5,000 10,000 15,000
0 - 10
11 - 20
21 - 30
31 - 40
41 - 50
51 - 60
61 - 70
71 - 80
> 80
Cases Male
400 300 200 100 100 200 300
0 - 10
11 - 20
21 - 30
31 - 40
41 - 50
51 - 60
61 - 70
71 - 80
> 80
DeathsFemale
0 0
1.1% 1.2% 0.2% 0.3%
2.6%
13.4%
19.2%
14.4%
10.7%
5.6%
2.0%
0.6%
2.5%
7.1%
7.2%
5.2%
4.0%
2.2%
0.7%
0.3%
70% 80% 20% 30%
0.5%
1.7%
5.2%
9.6%
20.7%
24.5%
13.8%
3.9%
0.6%
1.3%
2.3%
2.0%
4.2%
5.6%
2.2%
1.2%
6 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
As of 05 July 2020, geographical distribution of confirmed reported COVID-19 cases was available on 98% of cases
(162,418/165,618). Of all cases, 14.7% were reported from Chattogram division, 4.2% - from Rajshahi division, 3.3%
- from Khulna division, 3.0% - from Sylhet division, 2.1% - from Mymensingh division, 2.1% - from Rangpur division,
and 2.0% - from Barisal division.
The figure below is showing the daily distribution of reported confirmed COVID-19 cases per division (except
Dhaka), 16 April – 05 July 2020, Bangladesh.
Available data allows us to see how quickly the number of confirmed cases increased in different divisions in Bangladesh
by looking at the case doubling time in each division.
As of 05 July 2020, case doubling time is 7.5 days in Dhaka division: 7.9 days in Chattogram; in Khulna, Sylhet and
Rajshahi divisions – 8.0-8.5 days, in Rangpur, Mymensingh and Barisal divisions – 10.0 days.
The figure below is showing the case-doubling time of COVID-19 confirmed cases in all divisions starting from
the day each reported 10 confirmed cases, 06 July 2020, Bangladesh.
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
2,000
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Num
ber
of C
ase
s
Chattogram Mymensingh Rangpur Sylhet Rajshahi Khulna Barishal
10
100
1,000
10,000
100,000
0 10 20 30 40 50 60 70 80 90 100
Num
ber
of C
ase
s
Days since 10th Confirm Case
BSL CTG DHK KLN
MYM RSH RNP SYT
D2 D3 D5D8
D9
D15
D4 D6
D10
D12
D20
D40
D1
7 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
Case doubling time has increased in Dhaka city from 7 days in the last week to 7.5 days this week. Case are doubling
in Dhaka district and Faridpur district in 10 Days, Gazipur, Narayanganj, Munshiganj and Kishoreganj districts are
doubling at 11-day rate.
The figure below is showing the growth of COVID-19 confirmed cases in all districts of Dhaka division starting
from the day each reported 10 confirmed cases, 06 July 2020, Bangladesh.
In Chattogram division by 06 July 2020 case doubling time has increased in Chattogram district from 8 days in the
previous week to 8.5 days this week. Noakhali district shows 9 days, Cumilla and Cox’s Bazar district – 9.5 days, in
Chandpur, Laxmipur and Brahmanbaria districts the number of cases is doubling in more than 11 days.
The figure below is showing the growth of COVID-19 confirmed cases in all districts of Chattogram division
starting from the day each reported 10 confirmed cases, 06 July 2020, Bangladesh.
10
100
1,000
10,000
100,000
0 10 20 30 40 50 60 70 80 90 100
Num
ber
of C
ase
s
Days since 10th Confirm Case
Dhaka (District) Dhaka City
Faridpur Gazipur
Kishoreganj Munshiganj
Narayanganj
D1 D2 D3 D5D8
D15
D4 D6
D10
D12
D20
D40
D9
10
100
1,000
10,000
100,000
0 10 20 30 40 50 60 70 80 90 100
Num
ber
of C
ase
s
Days since 10th Confirm Case
Brahmanbaria Chandpur Chattogram
Cox's Bazar Cumilla Lakshmipur
Noakhali
D1 D2 D3 D5D8
D15
D4 D6 D7
D10
D12
D20
D40
8 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
The figures below are showing the daily distribution of reported confirmed COVID-19 cases and rolling three-
days average per division, 16 April – 05 July 2020, Bangladesh.
0
500
1,000
1,500
2,000
2,500
3,000
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Dhaka 3 per. Mov. Avg. (Dhaka)
0
150
300
450
600
750
900
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Chattogram 3 per. Mov. Avg. (Chattogram)
0
50
100
150
200
250
300
350
400
450
500
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Rajshahi 3 per. Mov. Avg. (Rajshahi)
0
50
100
150
200
250
300
350
400
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Khulna 3 per. Mov. Avg. (Khulna)
9 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
0
50
100
150
200
250
30016/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Rangpur 3 per. Mov. Avg. (Rangpur)
0
50
100
150
200
250
300
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Sylhet 3 per. Mov. Avg. (Sylhet)
0
30
60
90
120
150
180
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Mymensingh 3 per. Mov. Avg. (Mymensingh)
0
30
60
90
120
150
180
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Barishal 3 per. Mov. Avg. (Barishal)
10 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
The overall COVID-19 attack rate (the total number of cases divided by the total population) in Bangladesh has been on
a steady increase since the first reported confirmed COVID-19 case on 08 March 2020. On 06 July, Bangladesh attack
rate (AR) is 972.4 per 1 million and 100% (64/64) of districts with the total population of 170,306,468 people have
reported confirmed COVID-19 cases. In the current week (epidemiological week 27), COVID-19 weekly AR increased by
17.9%, in comparison to the previous week (954 and 659 respectively).
The figure below is showing the weekly COVID-19 attack rate, 08 March – 06 July 2020, Bangladesh.
According to the available data, the highest AR continues to be observed in the Dhaka division (2,586.5/1,000,000).
Within the Dhaka division, Dhaka city has the highest AR (10,467.5/1,000,000) followed by Narayanganj district
(1,527.1), Munshiganj (1,316.4), Faridpur (1,080.6), Gazipur (922.6), Madaripur (603.5), Gopalganj (576.4), Dhaka
district (561.9), ), Shariatpur (488.8), Kishoreganj (469.7), Rajbari (453.6), Manikganj (378.9), and the lowest AR 175.3
was reported from Tangail district.
The 2nd
highest COVID-19 AR is reported from Chattogram division (711.1/1,000,000), the AR in all the 11 districts is
over 300 per million. Within the division, Chattogram district reported the highest AR (1,098.1/1,000,000) followed by
Cox’s Bazar district (1,021.2), Bandarban (888.6), Noakhali (616.1), Cumilla (606.6), Feni (531.4), Rangamati (515.2),
Lakshmipur (463.2), Chandpur (362.7), and the lowest AR 350.8 was reported from Brahmanbaria District.
The 3rd
highest AR in the country was reported from Sylhet division (411.5/1,000,000) with the highest AR in Sylhet
district (631.2/100,0000) followed by Sunamganj (356.1), Habiganj (298.0), and Maulvibazar (213.3) district.
Barishal division has taken the fourth highest in the overall AR with 336.0/1,000,000 with the highest AR in Barishal
district (613.2/1,000,000) followed by Jhalokathi (299.8), Barguna (286.1), Patuakhali (282.5), Pirojpur (186.9) and the
lowest 151.9 in Bhola district.
Rajshahi division has overall AR (314.3/1,000,000) with the highest AR in Bogura district (826.7/1000000), followed by
Joypurhat (421.2), Rajshahi (352.6), Natore (277.0), Pabna (159.2), and Sirajganj (171.2), Chapainawabganj (125.8);
while AR in Naogaon districts is less than 40.0/1,000,000.
In Khulna division the overall AR is 287.9/1,000,00 while the highest AR district is Khulna district (691.3/1000000)
followed by Jhenaidah, (351.0), Kushtia (265.9), Narail (249.6), Chuadanga (227.5), Jashore (210.5), Satkhira (140.5),
Bagerhat (127.8) and the lowest 112.3 in Meherpur district.
0.0
1
0.0
2
0.1
0.3
1 4 14 32 56 8
6 131 1
97 2
77
386
514
659
809
954
0
100
200
300
400
500
600
700
800
900
1,000
1,100
w10 w11 w12 w13 w14 w15 w16 w17 w18 w19 w20 w21 w22 w23 w24 w25 w26 w27
Weekl
y A
ttack
Rate
per
Millio
n
Attack Rate
TOT/C/M
Poly. ( Attack Rate
TOT/C/M )
11 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
Although Mymensingh division reported an overall AR of 261.7/1,000,00, Mymensingh district reported high AR
(329.71000000), followed by Jamalpur (232.8), Netrakona (205.6) and Sherpur (147.0).
Rangpur division reported the lowest AR in the country (179.8/1,000,000). Within the division Rangpur district having
the highest AR (313.5/1000000) followed by Dinajpur (209.0), Nilphamari (186.8), Thakurgaon (137.5) and Panchagarh
(126.7), Lalmonirhat (104.4) and Kurigram (86.2).
The following figure is showing the COVID-19 attack rate per 1,000,000 population in selected divisions, 16 April
- 06 July 2020, Bangladesh.
Growth factor (every day's new cases / new cases on the previous day) between 0 and 1 indicates a decline; when it is
above 1 it signals an increase, and if is persistently above 1 this could signify exponential growth. On April 3, the Growth
factor (GF) for COVID-19 cases in Bangladesh reached the highest of 2.5, the GF was above 2 on 9 and 12 April. Since
the beginning of June 2020, the GF has been within the range of 0.8 – 1.2 and on 06 July 2020, it is 1.17.
The figure below is showing the Growth Factor of daily confirmed COVID-19 cases, 08 March – 06 July 2020,
Bangladesh.
0
100
200
300
400
500
600
700
800
16/0
4
20/0
4
24/0
4
28/0
4
02/0
5
06/0
5
10/0
5
14/0
5
18/0
5
22/0
5
26/0
5
30/0
5
03/0
6
07/0
6
11/0
6
15/0
6
19/0
6
23/0
6
27/0
6
01/0
7
05/0
7
Att
ack R
ate
/1,0
00,0
00
CTG RNP KLN MYM BSL RSH SYT
0.0
0.5
1.0
1.5
2.0
2.5
3.0
08/0
3
12/0
3
16/0
3
20/0
3
24/0
3
28/0
3
01/0
4
05/0
4
09/0
4
13/0
4
17/0
4
21/0
4
25/0
4
29/0
4
03/0
5
07/0
5
11/0
5
15/0
5
19/0
5
23/0
5
27/0
5
31/0
5
04/0
6
08/0
6
12/0
6
16/0
6
20/0
6
24/0
6
28/0
6
02/0
7
06/0
7
Gro
wth
Fact
or
12 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
As of 06 July 2020, according to the IEDCR, 863,307 COVID-19 tests with the overall positivity rate of 22.4% were
conducted in Bangladesh by 73 laboratories (39) laboratories in Dhaka city and (34) laboratories in outside Dhaka. The
latest laboratories, which have started the testing: in Dhaka - Universal Medical College Hospital Ltd., National Institute
of Biotechnology (NIB) and DNA Lab Limited. Outside Dhaka - International Medical College & Hospital, Gazipur. 62.5%
(537,810/863,307) of all samples were tested by laboratories in the Dhaka city, and 37.5% (322,497) - outside Dhaka.
The graph below is showing the weekly and cumulative number of COVID-19 conducted tests, 08 March – 06 July
2020, Bangladesh.
COVID-19 testing coverage has been gradually increasing in Bangladesh, reaching now 5,096/1,000,000: now almost
reached Sri Lanka (5,160/1,000,000) but is lower than Thailand (8,648/1,000,000), India (7,093/1,000,000), Nepal
(18,802/1,000,000), Malaysia (24,647/1,000,000) and Maldives (99,645/1,000,000).
The graph below is showing the daily, cumulative number of COVID-19 and tests per 1,000,000 population, 08
March – 06 July 2020, Bangladesh.
0
1000
2000
3000
4000
5000
6000
7000
0
3000
6000
9000
12000
15000
18000
21000
08-0
3
12-0
3
16-0
3
20-0
3
24-0
3
28-0
3
01-0
4
05-0
4
09-0
4
13-0
4
17-0
4
21-0
4
25-0
4
29-0
4
03-0
5
07-0
5
11-0
5
15-0
5
19-0
5
23-0
5
27-0
5
31-0
5
04-0
6
08-0
6
12-0
6
16-0
6
20-0
6
24-0
6
28-0
6
02-0
7
06-0
7
Test
s p
er
Millio
m
Num
ber
of Test
s (N
=863,3
07)
# Test # Cases Tests/1,000,000 Population
0 T
200 T
400 T
600 T
800 T
1,000 T
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Epi Week
Tests N =
Positive N =
08 March 2020
First Bangladesh case reported
863 Thousand
As of 06 July 2020
165,618
863,307
234 368 786 1,774 6,577 14,172 22,76434,845
41,123
115,865
52,821
68,175
65,347
89,057
106,478
110,699
118,033
13 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
The map below is showing the Dhaka city COVID-19 laboratories, number of cases and attack rate, 06
July 2020, Bangladesh.
14 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
As of 06 July 2020, the overall case doubling time in Bangladesh remains six and half (6.5) days.
Available data allows us to see how quickly the number of confirmed cases increased in Bangladesh and some other
countries in the WHO South-East Asia region: India, Indonesia, Thailand and Sri Lanka.
The figure below is showing the growth of COVID-19 confirmed cases in selected South East Asian countries
starting from the day they reported 100 confirmed cases, 06 July 2020.
As of 06 July 2020, the death doubling time in Bangladesh is twelve (12.0) days as of 06 July 2020, one day more than
in the previous update on 29 June 2020.
Available data allows us to see how quickly the number of confirmed deaths increased in Bangladesh and some other
countries in the WHO South-East Asia region: India, Indonesia, Thailand and Sri Lanka
The figure below is showing the growth of COVID-19 confirmed deaths in selected South East Asian countries
starting from the day they reported 100 confirmed cases, 06 July 2020.
100
1000
10000
100000
1000000
0 10 20 30 40 50 60 70 80 90 100 110
Num
ber
of C
ase
s
Days since 100th Confirm Case
India Indonesia
Malaysia Sri Lanka
Thailand Bangladesh
D1 D2 D3 D4 D5 D7
D40
D20
D15 D12
D10
D8
5
50
500
5000
0 10 20 30 40 50 60 70 80 90 100 110
Num
ber
of D
eath
s
Days since 5th Confirm Death
India Indonesia
Malaysia Sri Lanka
Thailand Bangladesh
D1 D2 D3 D5D4 D6 D7 D8
D10
D12
D15
D20
D40
15 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
4. Contact Tracing, Points of Entry (PoEs) and Quarantine
According to the DGHS, as of 06 July 2020, the current institutional quarantine capacity in the country is represented by
629 centres across 64 districts, which can receive 31,991 persons. A total of 19,912 individuals were placed in quarantine
facilities and of them 15,049 (75.6%) have been already released. By 06 July 2020, in total 31,594 individuals were
isolated in designated health facilitates all over the country, of them 14,755 (46.7%) have been released, and 16,839
(53.3%) are presently in isolation facilities which is 17.2% increase than the last week.
The highest number of people (6,547) in quarantine facilities was reported on 24 April 2020 while presently, the number
reduced to 4,864. Between 17 March to 06 July 2020, total 359,258 individuals were placed under home quarantine all
the over the county and to date 83.6% (300,275/359,258) have been already released. Remaining 16.4% (58,983
individuals) are in home quarantine now.
The figures below are showing the number of individuals in home quarantine and individuals in hospital
isolation, 16 Mach – 06 July 2020, Bangladesh.
1,3
87
8,7
94
15,4
24
23,5
37
19,5
53
16,6
65
12,2
43
5,7
50
1,5
15
3,7
60
12,6
38
26,2
90
30,1
73
61,6
33
64,0
05
62,1
07
59,9
03
56,7
49
55,6
01
56,2
95
36,6
32
36,0
34
34,2
20
38,1
65
32,1
59
42,0
08
44,0
59
46,0
85
48,8
83
51,2
43
51,6
45
52,3
91
54,6
16
56,6
10
55,4
65
54,2
54
53,6
35
52,0
71
53,1
80
55,5
49
57,2
37
57,9
06
58,6
42
59,1
67
59,2
26
60,0
02
59,7
90
59,5
45
60,3
97
59,3
11
58,9
70
59,6
81
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
16/0
3
20/0
3
24/0
3
28/0
3
01/0
4
05/0
4
09/0
4
13/0
4
17/0
4
21/0
4
25/0
4
29/0
4
03/0
5
07/0
5
11/0
5
15/0
5
19/0
5
23/0
5
27/0
5
31/0
5
04/0
6
08/0
6
12/0
6
16/0
6
20/0
6
24/0
6
28/0
6
02/0
7
06/0
7
Presently in Home Quarantine Total Home Quarantined Total Home Released
1,6
36
1,6
94
1,7
94
1,7
71
1,8
74
2,0
17
2,1
15
2,2
36
2,3
61
2,4
35
2,5
70
2,7
48
3,0
46
3,2
48
3,3
83
3,6
16
3,8
16
3,8
97
4,0
60
4,3
05
4,4
64
4,6
53
4,7
70
4,9
94
4,9
84
5,1
40
5,5
29
5,7
94
6,0
21
6,2
40
6,4
98
6,7
54
6,9
46
7,1
62
7,3
99
7,5
52
7,8
93
8,2
43
8,7
61
9,0
12
9,3
40
9,7
58
10,0
26
10,3
02
10,7
52
11,0
26
11,4
74
11,9
15
12,1
90
12,4
67
12,9
27
13,1
55
13,4
29
13,8
00
14,2
67
14,5
23
14,9
69
15,1
47
15,5
47
15,7
55
15,9
47
16,4
49
16,7
15
16,8
39
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
03/0
5
07/0
5
11/0
5
15/0
5
19/0
5
23/0
5
27/0
5
31/0
5
04/0
6
08/0
6
12/0
6
16/0
6
20/0
6
24/0
6
28/0
6
02/0
7
06/0
7
Presently in Isolation Hospital Isolation Released from Isolation
16 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
5. Case Management and Infection Control
On 2 and 6 July DGDA hosted two consultative meetings on minimum testing requirements of fabric masks for
community use, in the context of COVID-19. The purpose of the consultative meeting was to discuss the technical
aspects related to specifications and quality of fabric masks intended for use by the general public. The discussion was
based on a draft list of minimum testing requirements developed by the technical working group supported by USAID
and JICA and including technical experts from BUET, icddr,b and Japanese inspection firm K2, and technically led by
WHO. Participants included technical experts from laboratories approved by DGDA for quality testing of personal
protective equipment (PPE). Setting the specifications and testing requirements of cloth masks has become an urgent
priority as worldwide the use of masks is mandated or encouraged in many countries. WHO has also issued technical
guidance on the use of masks in the community. The consultative meeting discussed several issues related to the
Bangladesh context including types of fabric available, capacity of local testing laboratories, safety levels of chemicals
used in treating fabrics, design of masks and labelling information. A visual inspection checklist is also under
development by K2 to ensure the adherence of the bulk production with the technical specifications claimed by the
manufacturer. A final stakeholder consultation is planned with the manufacturers to capture any input from their side n
the requirements. DGDA aims to publish the requirements early next week. Full document:
https://apps.who.int/iris/rest/bitstreams/1279750/retrieve.
Technical support continues with local manufacturers of PPE aiming to improve adherence to the WHO requirements,
specified in the WHO disease commodity package for COVID-19. Since the beginning of the COVID-19 pandemic,
local textile and ready-made-garments manufacturers have taken initiative to repurpose their manufacturing lines to
produce different PPE items including coveralls, gowns, surgical masks and respirators. Several manufacturers have
refined their methods and are now exporting to the US and European markets. This gives a valuable opportunity for
ensuring the products locally available are compliant and with international standards.
DGHS has issued further guidance to health facilities on classification of PPE according to level of protection approved
by DGDA for the PPE products. The exercise involves capacity building of concerned staff at health facilities on the role
of PPE as part of the infection prevention and control practices. An important factor is identification of PPE according to
its classification. Supply chain solutions are needed to ensure appropriate identification and distribution of PPE at the
user-level, as many of the items look similar in design and colour and may not be easily identifiable to the user. This is
especially important for health professionals involved in surgical procedures, emergency care or other healthcare
activities which involve risk of exposure to body fluids, as the requirement of splash resistance is available in level 3 and
4 PPE. For other health care activities, in the context of COVID-19, the WHO DCP accepts all levels of PPE conforming
with the required standards.
WHO published interim guidance on Biomedical equipment for COVID-19 case management - inventory tool.
Countries can use this tool to collect in-depth facility inventories of biomedical equipment re-allocation, procurement
and planning for COVID-19 case management. The survey assesses quantified availability and the causes for non-
functioning of different sources of oxygen delivery and supply systems to the patient in order to determine priorities
and re-allocation requirements in accordance with needs. Content areas include: oxygen supplies and equipment;
respiratory instruments and equipment; suction devices; ventilators; and autoclaves/sterilizers. Target audiences include
facility managers; clinical decision-makers; procurement officers; planning officers; biomedical engineers; and
infrastructure engineers. Full document: https://apps.who.int/iris/rest/bitstreams/1284105/retrieve.
The Emergency Use Listing (EUL) scope for in vitro diagnostics (IVDs) to detect SARS-CoV-2 has been expanded
to include antibody detection enzyme immunoassays. The following IVDs are therefore eligible for EUL submission:
Assays for the detection of SARS-CoV-2 nucleic acid; Rapid diagnostic tests for the detection of IgM/IgG to SARS-CoV-
2; and Rapid diagnostic tests for the detection of SARS-CoV-2 antigens. To date, 47 expressions of interest for NAT
assays, 12 for antibody detection RDTs have been received so far. 13 products have been listed as eligible for WHO
procurement based on their compliance with WHO EUL requirements. Six products have been identified as not eligible
for procurement following the review. The WHO EUL assessments and support to in-country authorization or listing of
IVDs for COVID-19 are at the core of WHO’s support to market readiness and come to complement partners’ efforts
towards equal and adequate access to diagnostic tools. Updated EUL is available online at
https://www.who.int/diagnostics_laboratory/EUL/en/.
17 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 06 July 2020/Vol.19
Contact: Dr Bardan Jung Rana, WHO Representative to Bangladesh, [email protected]
Dr Hammam El Sakka, Senior Medical Epidemiologist, Team Leader, WHE, COVID-19 IM, WHO-BAN, [email protected]
6. Risk Communication and Public Awareness
Risk Communication and Community Engagement (RCCE) supports the DGHS in planning and execution of two media
information campaigns for better informing population about COVID-19 and the prevention measures. One of the
campaigns regards the use of cloth masks, importance and guidelines for correct use as well as for making masks at
home. The second campaign is an overarching communication and information project aimed at informing the
individuals and communities about generic prevention measures as well as for preventing stigma and discrimination,
emphasizing the role of communities not only individuals in addressing COVID. Basic information regarding personal
and community protective measures are already disseminated through RCCE partners social media platforms as well as
through community level channels such as mosques, posters distribution or community health workers. Both campaigns
are scheduled to be expanded in the upcoming period to further include mainstream media distribution (Radio, TV)
which will complement the social media and community channels and will ensure a wider distribution of the information.
7. Useful COVID-19 links:
WHO Bangladesh COVID-19 Situation Reports: https://www.who.int/bangladesh/emergencies/coronavirus-disease-
(covid-19)-update/coronavirus-disease-(covid-2019)-bangladesh-situation-reports
COVID-19 Situation in the WHO South-East Asia Region: https://www.who.int/southeastasia/outbreaks-and-
emergencies/novel-coronavirus-2019
Latest global WHO Situation Report # 167 as of 05 July 2020: https://www.who.int/emergencies/diseases/novel-
coronavirus-2019/situation-reports
WHO Bangladesh awareness and risk communication materials in Bengali:
https://www.who.int/bangladesh/emergencies/coronavirus-disease-(covid-19)-update
EPI-WIN: WHO information network for epidemics: https://www.who.int/teams/risk-communication
COVID-19 updates from the Directorate General of Health Services, Ministry of Health and Family Welfare,
Government of The People’s Republic of Bangladesh: https://dghs.gov.bd/index.php/en/home/5343-covid-19-update
Institute of Epidemiology, Disease Control and Research (IEDCR): https://www.iedcr.gov.bd/